Integra LifeSciences appoints Lea Daniels Knight as EVP and CFO

Princton-based Integra LifeSciences Holdings appointed Lea Daniels Knight as executive vice president and chief financial officer, effective Wednesday.

Knight has over 30 years of experience in global companies with significant operating scale and complexity, leading and developing high-performing teams and demonstrating success in combining financial acumen and business process leadership with strategic vision to deliver strong business outcomes.

Most recently, Knight served as the executive vice president of business finance for Booz Allen Hamilton, where she was responsible for providing strategic and financial leadership to all of the company’s business sectors to support above-market growth.

Prior to Booz Allen Hamilton, she worked at Johnson & Johnson for 18 years, assuming finance roles with increasing responsibility, including as chief financial officer of Johnson & Johnson’s North America pharmaceuticals business. Throughout her tenure at the company, Knight helped drive cost optimization initiatives, manage risk and create innovative solutions across six of the organization’s operating companies within their consumer, pharmaceutical and corporate sectors.

Knight started her career in public accounting at Arthur Andersen LLP, where she spent nine years managing large, technically complex audit engagements and helped to stand up the firm’s Healthcare Consulting and Mergers & Acquisitions practices for the Philadelphia office.

“Lea brings a wealth of finance, accounting and extensive health care industry experience, and has the necessary capabilities to successfully partner with me and our executive leadership to lead change and drive growth and financial outcomes,” Jan De Witte, CEO and president, Integra LifeSciences, said. “She is passionate about leadership and talent development with broad experience leading geographically dispersed teams that have outperformed and created shareholder value.”

“I deeply admire the company’s purpose of restoring patients’ lives and its mission of driving innovation and setting new treatment standards of care as it aligns with my own values,” Knight said. “I look forward to leveraging my experience in finance, health care, global business services and operational organizations, and build on Integra’s leadership position in surgical, neurologic and regenerative care to create long-term value for our customers, patients and shareholders.”